A combination of SB273005 and TMZ, when administered orally, an advantageous delivery route 68, efficiently suppressed the activation of pro-tumor transcription factors SOX2 and Nestin expression, leading to superior tumor suppression and prolonged overall survival time in orthotopic glioma models 69, 70. Here, SOX2 is linked to central nervous system cancer.